Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]... -

Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]...

wikipedia - 15 Sep 2016
Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]) is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer's primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers. The company is a component of the Euro Stoxx 50 stock market index. The company's motto is "science

Is Loxo Oncology's Deal With Bayer Bad News?

Motley Fool - 18 Nov 2017
After reporting that global biopharma giant Bayer AG (NASDAQOTH:BAYRY) has inked a licensing deal for its most advanced clinical-stage drug, shares in Loxo Oncology (NASDAQ:LOXO) tumbled. Is teaming up with Bayer a bad move for the company?

One million+ Consumers Call On DOJ To Block Bayer-Monsanto Merger

Los Alamos Daily Post - 21 Nov 2017
WASHINGTON, D.C. — More than 1 million petition signatures were delivered last week by farming, consumer and environmental groups to the U.S. Department of Justice calling on the department to block the proposed merger of Bayer (BAYN) and ...

Staph buster LA BioMed's CEO Dr. Arnold Bayer

Easy Reader - 21 Nov 2017
For the past several decades, Dr. Arnold Bayer has researched, shapeshifting bacteria in an effort to penetrate their defenses and render them harmless. In the course of his work, the Rancho Palos Verdes resident has earned world renown for furthering ...

From Bayer to Qualcomm, M&A Gets Costlier in the EU

Bloomberg - 12 Nov 2017
Bayer AG's bid for Monsanto Co. is just one of a growing number of deals stalled by regulators stopping the clock more than once during strictly timetabled in-depth investigations to demand key information they say companies failed to supply on time.

Confident Bayer Leverkusen show their potential

Deutsche Welle - 18 Nov 2017
"Both teams have quality," the forward added. "We're two teams on the same level." Whether that really is the case will become clear at the end of the season, and the two clubs still have very different ambitions. But Bayer Leverkusen certainly showed ...

Bayer in bid to broaden use of anti-clotting drug Xarelto

Reuters - 06 Nov 2017
FRANKFURT (Reuters) - German drugmaker Bayer on Monday moved to tap a potentially lucrative new market opportunity for its blockbuster clot prevention drug Xarelto, requesting approval in Europe to make atherosclerosis patients eligible for treatment.

EU resumes Bayer-Monsanto deal review; new deadline March 5 - 06 Nov 2017
The European Commission has resumed its antitrust review of Bayer's planned takeover of U.S. seed maker Monsanto after the companies were given time to provide more information. The new deadline for the Commission to decide over the deal is now ...

Bayer Looking for FiberMax One Ton Club Growers for 2017

Cotton Grower - 16 Nov 2017
“Growers need an advanced skill-set and elite germplasm to produce excellent yields,” says Kerry Grossweiler, Bayer campaign manager. “The FiberMax One Ton Club allows us to celebrate a grower's knowledge and accomplishments and applaud them for ...

Bayer Earns Top Marks In 2018 Corporate Equality Index

PR Newswire (press release) - 14 Nov 2017
WHIPPANY, N.J., Nov. 14, 2017 /PRNewswire/ -- For the first time, Bayer has received a perfect score of 100 percent on the 2018 Corporate Equality Index (CEI), a nationwide benchmarking survey and report on corporate policies and practices important to ...

Bayer Leverkusen starlet Kai Havertz attracting Liverpool interest

ESPN FC (blog) - 10 Nov 2017
Only a few months later, at 17 years and 126 days, Havertz became the youngest ever player to wear the Bayer jersey. There was no stopping him from there. He made his Champions League debut only a few days later, coming on as a late substitute in a 1-0 ...

Opponents: Bayer purchase of Monsanto will hurt farmers, consumers

Fence Post - 15 Nov 2017
From left, Joe Maxwell, executive director of the Organization for Competitive Markets, introduces a panel to discuss the Bayer-Monsanto merger. Seated from left: Bill Bullard of R-CALF, Leah Douglas of the Open Markets Institute, Erich Pica of Friends ...

What's New